• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beryl Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3982.0
  • ISIN : INE415H01017
25.87 1 (3.48%)
  • As on 07 Nov 2026 (EOD)

  • Today’s Low

    23.97

  • Today’s High

    26.00

  • Open

    24.99

  • Perv Close

    25.00

  • 52W Low

    15.92

  • 52W High

    27.90

Key Indicators

  • P/E(TTM)

    21.03

  • Mar.Cap (₹Cr.)

    13.12

  • Div & Yield %

    0.00

  • Book Value(₹)

    19.45

  • Debt-Equity Ratio

    3.48

  • AGM Date

    06-Nov-2026

  • EPS

    1.23

  • P/E Ratio

    21.03

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    13.12

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.07

  • BV (₹)

    19.50

  • Sales( ₹ in Cr.)

    18.82

  • NP (in Cr.)

    0.42

  • NP Var(%)

    -25.0

  • Div%

    0.0

  • CPS (₹)

    3.80

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    13.12

  • 52 Week High

    27.90

  • 52 Week Low

    15.92

  • Price BSE

    26.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    13.12

  • P/C Ratio

    6.90

  • P/E Ratio

    31.00

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 18.82 21.15 26.73 26.89 14.60 14.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 18.82 21.15 26.73 26.89 14.60 14.09
Other Income 0.49 1.41 0.40 0.27 0.16 0.64
Stock Adjustments 0.74 0.34 0.17 -0.31 0.30 0.03
Total Income 20.05 22.90 27.30 26.85 15.06 14.76
EXPENDITURE :            
Raw Materials 1.28 1.12 1.48 1.25 0.90 0.76
Power and Fuel Cost 1.30 1.25 1.54 1.27 0.85 0.86
Employee Cost 2.53 2.21 1.93 1.70 1.31 1.18
Other Manufacturing Expenses 11.61 12.75 15.02 15.78 9.04 7.90
Selling and Administration Expenses 0.90 2.88 4.64 4.50 2.16 1.92
Miscellaneous Expenses 0.00 0.02 0.00 0.07 0.21 0.06
Employee Benefit Expenses 2.53 2.21 1.93 1.70 1.31 1.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 17.63 20.24 24.61 24.58 14.48 12.67
Operating Profit 2.43 2.65 2.68 2.27 0.60 2.09
Interest 0.35 0.54 0.47 0.47 0.46 0.47
Gross Profit 2.08 2.11 2.21 1.80 0.14 1.62
Depreciation 1.49 1.26 1.20 0.81 1.09 1.27
Profit Before Tax 0.59 0.85 1.01 0.99 -0.95 0.35
Current Tax 0.11 0.19 0.44 0.16 0.01 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 0.10 -0.20 0.06 -0.30 0.11
Reported Net Profit 0.42 0.57 0.77 0.77 -0.66 0.24
Extraordinary Items 0.00 0.00 0.01 0.00 0.00 0.34
Adjusted Net Profit 0.42 0.57 0.76 0.77 -0.66 -0.10
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 4.32 3.76 3.00 2.23 2.89 2.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 4.75 4.32 3.77 3.00 2.23 2.89
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.83 1.11 1.51 1.50 -1.29 0.47
Earnings Per Share(Adj)-Unit Curr 0.83 1.11 1.51 1.50 -1.29 0.47
Book Value 19.41 18.61 17.52 15.84 14.32 15.57
Book Value(Adj)-Unit Curr 19.41 18.61 17.52 15.84 14.32 15.57

Shareholding Pattern

  • Promoter Group

    27.97%

  • Public Share Holding

    72.03%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,418,559 27.97 1,418,559 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,418,559 27.97 1,418,559 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 136,199 2.69 100,299 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 204,554 4.03 192,754 42
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 51,450 1.01 51,450 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 729,489 14.38 729,489 13
Individuals holding nominal share capital up to Rs. 1 lakh 2,489,289 49.08 1,300,489 7,155
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 42,160 0.83 42,160 40
Sub Total 3,653,141 72.03 2,416,641 7,292
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,071,700 100.00 3,835,200 7,296

Company Background

Beryl Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Beryl Drugs Ltd
  • BSE Code : 3982.0
  • ISIN : INE415H01017

  • Incorporation Year

    1993

  • Registered Office

    29 Neer Nagar Mayank Water
    Park Road Bicholi, Indore,
    Madhya Pradesh-452016

  • Telephone

  • FAX

  • Chairman

    Sudhir Sethi

  • Managing Director

    Sanjay Sethi

  • Company Secretary

    Neha Sharma

  • Auditor

    Subhash Chand Jain Anurag & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Beryl Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beryl Drugs 25.87 19.31 18.82 21.03 6.93
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77